INS and diabetes mellitus: This study supports the need for continued advocacy by T1International and others unbiased by pharmaceutical and industry funding, healthcare systems improvements at the governmental level, and price reductions of insulin and diabetes supplies at the global level to ensure adequate, equitable access to insulin and diabetes supplies, including advanced technologies, for all.